The intersection of artificial intelligence (AI) and drug development has ushered in a transformative era, revolutionizing the way researchers approach biomarker/target identification, drug/target interactions, and drug-like molecule design. Rooted in an interdisciplinary fusion of computer science, statistics, and biology, AI in the life sciences seeks to unravel intricate biological...